Sector
MiscellaneousOpen
₹54.15Prev. Close
₹57Turnover(Lac.)
₹1.62Day's High
₹54.15Day's Low
₹54.1552 Week's High
₹101.6452 Week's Low
₹37Book Value
₹31.27Face Value
₹10Mkt Cap (₹ Cr.)
34.18P/E
0EPS
0Divi. Yield
06 Sep 2023
12:00 AM
AGM
Announcement Date: 06 Sep, 2023
10 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 6.31 | 6.31 | 6.31 | 6.31 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.43 | 17.68 | 17.6 | 17.13 |
Net Worth | 19.74 | 23.99 | 23.91 | 23.44 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 10.03 | 14.11 | 3.98 | 0 |
yoy growth (%) | -28.87 | 254.06 | 0 | |
Raw materials | -0.81 | -1.17 | -0.32 | 0 |
As % of sales | 8.15 | 8.35 | 8.09 | 0 |
Employee costs | -2.82 | -4.93 | -1.61 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.6 | 1.28 | 0.31 | 0 |
Depreciation | -1.25 | -1.18 | -0.57 | 0 |
Tax paid | -0.13 | -0.31 | -0.28 | 0 |
Working capital | -4.9 | 10.76 | 2.88 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -28.87 | 254.06 | 0 | |
Op profit growth | -9.79 | 318.76 | 0 | |
EBIT growth | -17.69 | 532.91 | 0 | |
Net profit growth | -51.91 | 3,483.37 | 0 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 9.72 | 6.28 | 9.69 | 10.04 | 14.14 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 9.72 | 6.28 | 9.69 | 10.04 | 14.14 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.11 | 0.69 | 0.42 | 0.03 | 0.11 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Godrej Agrovet Ltd GODREJAGRO | 806.9 | 43.27 | 15,513.51 | 36.44 | 1.24 | 1,486.97 | 117.5 |
Indegene Ltd INDGN | 570.25 | 99 | 13,644.31 | 48.9 | 0 | 272.5 | 71.66 |
Thomas Cook (India) Ltd THOMASCOOK | 241.05 | 113.7 | 11,343.55 | 17.16 | 0.25 | 284.95 | 39.36 |
RattanIndia Enterprises Ltd RTNINDIA | 74.06 | 20.02 | 10,237.09 | -80.74 | 0 | 2.01 | 6.86 |
CMS Info Systems Ltd CMSINFO | 520.85 | 24.41 | 8,477.47 | 111.31 | 1.1 | 580.71 | 116.06 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Mohan Krishna Mulakala
Managing Director
Dopesh Raja Mulakala
Whole-time Director
Vyasmurti Madhavrao Shingatgeri
Independent Director
Padmanabhuni Venkata Appaji
Company Secretary
Zoheb Sayani
Whole Time Director & CEO
Sadhanala Venkata Rao
Addtnl Independent Director
Yogeswara Rao Danda
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vanta Bioscience Ltd
Summary
Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name Vanta Bioscience Private Limited. The Company converted into a Public Limited Company and the name was changed to Vanta Bioscience Limited on 17th March 2017.The Company is presently engaged in the business of Preclinical Activities. The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as Vanta Bioscience (a toxicology division and commenced commercial activities in
Read More
What is the Vanta Bioscience Ltd share price today?
The Vanta Bioscience Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹54.15 today.
What is the Market Cap of Vanta Bioscience Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vanta Bioscience Ltd is ₹34.18 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Vanta Bioscience Ltd?
The PE and PB ratios of Vanta Bioscience Ltd is 0 and 1.82 as of 22 Jul ‘24
What is the 52 Week High and Low of Vanta Bioscience Ltd?
The 52-week high/low is the highest and lowest price at which a Vanta Bioscience Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vanta Bioscience Ltd is ₹37 and ₹101.64 as of 22 Jul ‘24
What is the CAGR of Vanta Bioscience Ltd?
Vanta Bioscience Ltd's CAGR for 5 Years at -15.07%, 3 Years at -26.75%, 1 Year at 23.67%, 6 Month at 3.45%, 3 Month at -9.80% and 1 Month at 9.09%.
What is the shareholding pattern of Vanta Bioscience Ltd?
The shareholding pattern of Vanta Bioscience Ltd is as follows:
Promoters - 69.36 %
Institutions - 0.00 %
Public - 30.64 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
